Runway to a Cure is an annual fashion show fundraiser that benefits The Leukemia & Lymphoma Society (LLS) in their mission to find cures for blood cancer and improve the quality of life for patients and their families.
Each year Runway to a Cure supports a candidate for the LLS Man & Woman of the Year campaign. This year, we're taking it to the next level in the National All-Star Campaign, where former MWOY candidates choose to participate once again. We are happy to announce that this year's Runway to a Cure event will support Sabrina Mosseau, as she competes for the second time to raise the most funds for LLS and become the 2018 National All-Star Woman of the Year!
The Man & Woman of the Year campaign is a national 10-week fundraising competition to raise funds to support the mission of LLS. In the National All-Star Campaign, the male and female candidates from across the U.S. who raise the most funds are awarded the National title of All-Star Man & Woman of the Year. This year the Upstate New York/Vermont Chapter of LLS is campaigning in honor of the local Boy & Girl of the year, Evan Fronk (Age 6)and Bella Caruso (Age 6), each a brave survivor of blood cancer.
Cancer is the leading cause of death worldwide. More than 1.2 million people in the US are living with blood cancer and more than 14 million people overall are living with some form of cancer.
Every 3 minutes, someone is diagnosed with blood cancer.
Every 10 minutes, someone loses their life to blood cancer. That amounts to 6 people every hour and about 144 people every day.
Despite significant progress, more than a third of blood cancer patients do not survive five years after their diagnosis.
Leukemia causes more deaths than any other cancer among children under the age of 20.
In 1964, the 5-yr survival rate for children with ALL was 3%. Today, it's approximately 90%.
Lymphomas are the most common blood cancers, and incidence increases with age.
March is Myeloma awareness month:
Approximately 96,000 people in the US are living with Myeloma.
Myeloma has a survival rate of only 41%.
Why Support LLS?
Over 40% of new cancer therapies approved by the FDA from 2000-2014 were first approved for blood cancer patients. Each year more and more treatments that were originally designed and tested for blood cancer patients are being tested and applied to other cancers and serious diseases, including breast, colon, and pancreatic cancer, rheumatoid arthritis, and Parkinson's disease.
Last year alone, LLS:
invested $67.2 million in research.
funded $41.8 million in co-pay assistance to blood cancer patients.
funded almost 7,800 customized clinical trials.
responded to over 60,000 inquiries through the LLS toll free Information Resource Center (IRC).
matched over 1,000 patients with trained volunteers who have firsthand experience with blood cancer through the LLS first connection program.
and much more!
PLEASE CONSIDER attending our event & SUPPORTING the Lls mwoy CAMPAIGN. all donations, big & small, help bring us closer to a cure!